1. Home
  2. FSTR vs ALT Comparison

FSTR vs ALT Comparison

Compare FSTR & ALT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FSTR
  • ALT
  • Stock Information
  • Founded
  • FSTR 1902
  • ALT 1997
  • Country
  • FSTR United States
  • ALT United States
  • Employees
  • FSTR N/A
  • ALT N/A
  • Industry
  • FSTR Metal Fabrications
  • ALT Biotechnology: Pharmaceutical Preparations
  • Sector
  • FSTR Industrials
  • ALT Health Care
  • Exchange
  • FSTR Nasdaq
  • ALT Nasdaq
  • Market Cap
  • FSTR 285.6M
  • ALT 333.6M
  • IPO Year
  • FSTR N/A
  • ALT N/A
  • Fundamental
  • Price
  • FSTR $25.90
  • ALT $3.95
  • Analyst Decision
  • FSTR Hold
  • ALT Strong Buy
  • Analyst Count
  • FSTR 1
  • ALT 6
  • Target Price
  • FSTR $25.00
  • ALT $17.40
  • AVG Volume (30 Days)
  • FSTR 27.3K
  • ALT 2.6M
  • Earning Date
  • FSTR 11-06-2025
  • ALT 11-11-2025
  • Dividend Yield
  • FSTR N/A
  • ALT N/A
  • EPS Growth
  • FSTR 395.33
  • ALT N/A
  • EPS
  • FSTR 3.32
  • ALT N/A
  • Revenue
  • FSTR $506,999,000.00
  • ALT $20,000.00
  • Revenue This Year
  • FSTR $3.93
  • ALT N/A
  • Revenue Next Year
  • FSTR $4.51
  • ALT N/A
  • P/E Ratio
  • FSTR $7.80
  • ALT N/A
  • Revenue Growth
  • FSTR N/A
  • ALT N/A
  • 52 Week Low
  • FSTR $17.16
  • ALT $2.90
  • 52 Week High
  • FSTR $29.78
  • ALT $11.16
  • Technical
  • Relative Strength Index (RSI)
  • FSTR 46.48
  • ALT 52.90
  • Support Level
  • FSTR $26.22
  • ALT $3.85
  • Resistance Level
  • FSTR $26.90
  • ALT $4.06
  • Average True Range (ATR)
  • FSTR 0.81
  • ALT 0.23
  • MACD
  • FSTR -0.25
  • ALT 0.02
  • Stochastic Oscillator
  • FSTR 4.48
  • ALT 51.92

About FSTR L.B. Foster Company

L.B. Foster Co is a U.S-based firm engaged in the manufacturing, fabrication, and distribution of products and services, especially for the rail, construction, energy, and utility industries. The company operates its business through two segments: Rail Technologies and Services and Infrastructure Solutions. Its principal business activity involves providing new and used rail, trackwork, and accessories, producing concrete railroad ties, insulated rail joints, power rail, track fasteners, cover boards, and sales of sells and rents steel sheet piling, H-bearing pile, and other piling products for foundation and earth retention requirements. It generates the majority of its revenues from the Rail Technologies and Services segment.

About ALT Altimmune Inc.

Altimmune Inc is a clinical-stage biopharmaceutical company focused on developing treatments for obesity, metabolic diseases, and liver diseases. Its product candidate, pemvidutide (formerly known as ALT-801), is a novel, investigational, peptide-based GLP-1/glucagon dual receptor agonist. Pemvidutide is currently in clinical development for obesity and metabolic-associated steatohepatitis (MASH). The company also plans to pursue additional indications for pemvidutide that leverage the differentiated clinical profile of pemvidutide.

Share on Social Networks: